Skip to main content

Table 2 Mean and median direct and indirect costs during pre-treatment and treatment periods for TB patients in the ACF and PCF cohorts (VNĐ1 = US$0.0000436, 2018-2019)

From: Socio-protective effects of active case finding on catastrophic costs from tuberculosis in Ho Chi Minh City, Viet Nam: a longitudinal patient cost survey

Cost item ACF (N = 52) PCF (N = 46) All (N = 98) P-valuea
Mean (95% CI) Median (IQR) Mean (95% CI) Median (IQR) Mean (95% CI) Median (IQR)  
Pre-treatment
Direct medical 37 (18-56) 13 (4-31) 151 (70-231) 75 (30-168) 90 (50-130) 29 (11-81) <0.001*
Direct non-medical 7 (2-12) 2 (0-4) 6 (3-9) 3 (1-8) 7 (4-9) 2 (1-6) 0.1394
Total directb 44 (22-66) 17 (6-34) 155 (73-238) 78 (32-154) 96 (55-137) 34 (11-88) <0.001*
Indirect, time loss 5 (0-10) 1 (0.5-1) 20 (3-36) 2 (1-5) 12 (4-20) 1 (1-3) <0.001*
Total pre-treatment 49 (24-74) 18 (7-37) 175 (85-264) 80 (33-203) 108 (63-153) 35 (13-90) <0.001*
Treatment
Direct medical 54 (39-70) 34 (22-61) 384 (76-693) 76 (37-154) 209 (63-355) 47 (24-93) <0.001*
Direct non-medical 44 (31-57) 27 (12-59) 43 (14-71) 14 (8-38) 43 (29-58) 20 (10-47) 0.056
Total directb 98 (74-122) 66 (43-121) 427 (98-756) 90 (50-195) 253 (97-408) 83 (46-160) 0.067
Indirect, time loss 13 (7-20) 6 (4-13) 27 (1-53) 5 (4-8) 20 (7-33) 5 (4-11) 0.144
Total treatment 112 (85-139) 73 (47-143) 454 (105-804) 95 (55-202) 273 (108-438) 91 (50-174) 0.109
Total costs (pre-treatment + treatment)
Direct medical 91 (68-115) 62 (34-123) 535 (169-902) 166 (98-289) 230 (125-474) 105 (47-196) <0.001*
Direct non-medical 51 (37-65) 34 (14-73) 48 (19-79) 19 (13-44) 50 (34-65) 23 (13-59) 0.095
Total Direct 142 (84-139) 106 (72-200) 582 (205-925) 179 (99-351) 349 (153-505) 131 (84-258) 0.001*
Income loss 273 (145-400) 71 (0-272) 627 (384-869) 414 (0-931) 439 (304-573) 134 (0-761) 0.032*
Time loss 18 (10-27) 8 (5-15) 47 (11-83) 9 (6-23) 32 (14-49) 8 (5-19) 0.693
Total Indirect 291 (163.7-419.0) 115 (12-307) 674 (436-912) 460 (59-938) 471 (337-605) 166 (23-765) 0.003*
Total costs 434 (301-566) 279 (122-468) 1,256 (807-1,706) 894 (234-1359) 820 (587-1,053) 413 (168-1,046) <0.001*
  1. aWilcoxon Rank Sum;
  2. bNet value: reimbursement deducted
  3. * Statistically significant difference at 95 % confidence level